Sign Up Today and Learn More About WHOOP Stock
Invest in or calculate the value of your shares in WHOOP or other pre-IPO companies through EquityZen's platform.
WHOOP Stock (WHOO)
WHOOP claims to unlock peak performance for athletes. Their wearable technology tracks biometrics and delivers personalized insights on training, recovery, and sleep.
WHOOP develops wearable fitness devices.
About WHOOP Stock
Founded
2012
Total Funding
416M
Industries
Hardware, Data and Analytics, Health Care
WHOOP is the developer of a wearable health and fitness tracking device. WHOOP says its device uses sensors to analyze biometric data and act as a personalized coach to offer advice on areas such as training, recovery, and nutrition. The company claims 99% accuracy for tracking heart rate and HRV. WHOOPS data insights work toward the company's mission of revolutionizing the way people understand their bodies and unlocking human performance.Â
WHOOP was founded in 2012 and is headquartered in Boston, MA. Notable investors include SoftBank Vision Fund, Two Sigma Ventures, and Silicon Valley Bank.Â
WHOOP Press Mentions
Stay in the know about the latest news on WHOOP
This wearable now offers free blood analysis to help you understand your health
techradar • Oct 06, 2025
Forget Whoop: This fitness band effectively tracked my workouts and has no subscription
zdnet • Oct 06, 2025
Gear News of the Week: Adobe Premiere Lands on iPhone, and Nothing Lets You Design Your Own Widgets
wired • Oct 04, 2025
Whoop Adds Bloodwork Uploads Amid Spat With FDA Over How 'Medical' Its Wearable Is
pcmag • Oct 03, 2025
I've been testing wearables for years, and I was still shocked by my smartwatch's ability to read my dreams
techradar • Oct 01, 2025
Investors in WHOOP
Discover investors in WHOOP stock and explore their portfolio companies
WHOOP Management
Leadership team at WHOOP
Co-Founder & Chief Executive Officer
Will Ahmed
Co-Founder & Chief Hardware Engineer
Aurelian Nicolae
Join now and verify your accreditation status to gain access to:
- WHOOP Current Valuation
- WHOOP Stock Price
- WHOOP Management
- Available deals in WHOOP and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- WHOOP Cap Table and Funding History by Share Class and Liquidity Preferences
- WHOOP Revenue and Financials
- WHOOP Highlights
- WHOOP Business Model
- WHOOP Risk Factors
- WHOOP Research Report from SACRA Research
WHOOP Key Facts
- Pioneering Integration of Lab Diagnostics and Wearable Data: WHOOP is cementing its position as a leader in health optimization by launching WHOOP Advanced Labs in September 2025. This groundbreaking feature integrates periodic blood biomarker testing (powered by Quest Diagnostics) with continuous 24/7 wearable data. It is clinically reviewed and provides members with personalized recommendations and AI-powered coaching, effectively bridging the gap between at-home monitoring and clinical diagnostics. The feature saw massive initial demand, with over 350,000 members joining the waitlist since its May preview.
- Strategic Expansion into Global Elite Sports Sponsorships: The company is strengthening its brand reputation and visibility by securing major partnerships in elite global sports. In June 2025, WHOOP was named the Official Supplier for the 2025 British & Irish Lions Tour to Australia, providing its cutting-edge WHOOP 5.0 wearable technology to all players and staff. This follows its partnership with the Ryder Cup in September 2025, which provides unprecedented, real-time access to the physiological data of world-class golfers on NBC broadcasts. These high-profile sponsorships validate the device's accuracy and performance in high-pressure environments.
- Deepened Focus on Healthspan and Clinical Metrics: WHOOP is strategically moving further into the health and wellness space by focusing on clinical-grade metrics. Its recent product launches include features like an FDA-cleared ECG, Healthspan (which quantifies "Pace of Aging"), and first-of-its-kind wearable Blood Pressure Insights. This dedication to clinically relevant data and long-term health metrics helps to differentiate WHOOP from competitors that primarily focus on basic fitness tracking and positions the company to potentially integrate with or be reimbursed by healthcare providers in the future.
- Intensified Competition from Subscription-Free Alternatives: The competitive landscape poses a significant threat, particularly from the smart ring sector. Rivals like Oura Ring offer a cheaper long-term alternative, with its monthly subscription fee being significantly lower than WHOOP's annual membership, as noted in a recent comparison. Furthermore, the rise of competitors who offer a subscription-free model with similar basic biometrics means WHOOP must continually justify its high, mandatory recurring cost against cheaper options, risking customer churn among budget-conscious consumers.
- Niche Market Focus and Limited Mass Appeal: WHOOP targets a specific segment of the market which includes mostly conscious individuals, athletes, and fitness enthusiasts who all care about optimizing their performance. The Verge published an article where the writer voiced the sentiment that WHOOP is for a "small subset of wealthy athletes." However, this is still a niche audience compared to the broader fitness and wearable market who also target lifestyle customers in addition to athletes. Because of this WHOOP could turn away casual users which may prevent the company from achieving mass-market success.
- Regulatory Scrutiny of New Medical Features: WHOOP's strategic move into medical features, such as its new Blood Pressure Insights (BPI), has drawn regulatory attention. In a July 2025 letter, the FDA questioned WHOOP's marketing of BPI without explicit marketing authorization, noting that the feature "would provide a user with a daily estimation of their blood pressure." Although WHOOP stated its belief that BPI is not a medical device, this regulatory scrutiny could force costly modifications, restrict the marketing of high-value features, and introduce significant legal liability for the company.
Trading WHOOP Stock
How to invest in WHOOP stock?
Accredited investors can buy pre-IPO stock in companies like WHOOP through EquityZen funds. These investments are made available by existing WHOOP shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell WHOOP stock?
Shareholders can sell their WHOOP stock through EquityZen's private company marketplace. EquityZen's network includes over 390K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 48K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
